Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Glaxosmithkline Pharmaceuticals Ltd, Data Patterns (India) Ltd, Gland Pharma Ltd and Indian Renewable Energy Development Agency Ltd are among the other gainers in the BSE's 'A' group today, 09 November 2026.
Bajaj Consumer Care Ltd soared 8.31% to Rs 444 at 11:44 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 86036 shares were traded on the counter so far as against the average daily volumes of 47662 shares in the past one month.
Glaxosmithkline Pharmaceuticals Ltd surged 7.75% to Rs 2735.7. The stock was the second biggest gainer in 'A' group. On the BSE, 23628 shares were traded on the counter so far as against the average daily volumes of 6937 shares in the past one month.
Data Patterns (India) Ltd spiked 7.28% to Rs 3969.45. The stock was the third biggest gainer in 'A' group. On the BSE, 1.03 lakh shares were traded on the counter so far as against the average daily volumes of 30431 shares in the past one month.
Gland Pharma Ltd exploded 7.19% to Rs 3350.95. The stock was the fourth biggest gainer in 'A' group. On the BSE, 92434 shares were traded on the counter so far as against the average daily volumes of 80333 shares in the past one month.
Indian Renewable Energy Development Agency Ltd spurt 5.90% to Rs 118.06. The stock was the fifth biggest gainer in 'A' group. On the BSE, 16.68 lakh shares were traded on the counter so far as against the average daily volumes of 4.12 lakh shares in the past one month.
Indian Renewable Energy Development Agency Ltd, Honasa Consumer Ltd, Finolex Cables Ltd, Gland Pharma Ltd are among the other stocks to see a surge in volumes on NSE today, 09 November 2026.
Glaxosmithkline Pharmaceuticals Ltd witnessed volume of 6.93 lakh shares by 14:09 IST on NSE, a 8.84 times surge over two-week average daily volume of 78447 shares. The stock increased 5.79% to Rs.2,686.70. Volumes stood at 10560 shares in the last session.
Indian Renewable Energy Development Agency Ltd notched up volume of 334.92 lakh shares by 14:09 IST on NSE, a 7.08 fold spurt over two-week average daily volume of 47.28 lakh shares. The stock rose 6.72% to Rs.118.81. Volumes stood at 13.39 lakh shares in the last session.
Honasa Consumer Ltd clocked volume of 56.62 lakh shares by 14:09 IST on NSE, a 6.7 times surge over two-week average daily volume of 8.45 lakh shares. The stock gained 3.58% to Rs.486.90. Volumes stood at 1.65 lakh shares in the last session.
Finolex Cables Ltd registered volume of 59.14 lakh shares by 14:09 IST on NSE, a 6.17 fold spurt over two-week average daily volume of 9.59 lakh shares. The stock slipped 6.19% to Rs.1,228.00. Volumes stood at 51.88 lakh shares in the last session.
Gland Pharma Ltd notched up volume of 21 lakh shares by 14:09 IST on NSE, a 6.02 fold spurt over two-week average daily volume of 3.49 lakh shares. The stock rose 6.42% to Rs.3,334.00. Volumes stood at 1.01 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd, SignatureGlobal India Ltd, Great Eastern Shipping Company Ltd, Mangalore Refinery And Petrochemicals Ltd are among the other stocks to see a surge in volumes on NSE today, 28 September 2026.
Tata Teleservices (Maharashtra) Ltd saw volume of 691.36 lakh shares by 14:14 IST on NSE, a 40.56 fold spurt over two-week average daily volume of 17.05 lakh shares. The stock increased 5.63% to Rs.36.38. Volumes stood at 17.75 lakh shares in the last session.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 3.97 lakh shares by 14:14 IST on NSE, a 6.63 times surge over two-week average daily volume of 59839 shares. The stock gained 3.11% to Rs.2,903.40. Volumes stood at 15380 shares in the last session.
SignatureGlobal India Ltd witnessed volume of 13.95 lakh shares by 14:14 IST on NSE, a 4.4 times surge over two-week average daily volume of 3.17 lakh shares. The stock dropped 1.10% to Rs.780.20. Volumes stood at 3.27 lakh shares in the last session.
Great Eastern Shipping Company Ltd notched up volume of 29.39 lakh shares by 14:14 IST on NSE, a 3.93 fold spurt over two-week average daily volume of 7.47 lakh shares. The stock rose 2.26% to Rs.1,531.10. Volumes stood at 4.54 lakh shares in the last session.
Mangalore Refinery And Petrochemicals Ltd notched up volume of 188.06 lakh shares by 14:14 IST on NSE, a 3.57 fold spurt over two-week average daily volume of 52.73 lakh shares. The stock rose 3.29% to Rs.170.01. Volumes stood at 32.45 lakh shares in the last session.
Coromandel International Ltd, Rashtriya Chemicals & Fertilizers Ltd, IIFL Finance Ltd, Paradeep Phosphates Ltd are among the other stocks to see a surge in volumes on BSE today, 25 August 2026.
Glaxosmithkline Pharmaceuticals Ltd saw volume of 2.31 lakh shares by 10:45 IST on BSE, a 12.83 fold spurt over two-week average daily volume of 17984 shares. The stock increased 0.47% to Rs.2,944.20. Volumes stood at 3455 shares in the last session.
Coromandel International Ltd clocked volume of 8.65 lakh shares by 10:45 IST on BSE, a 12.11 times surge over two-week average daily volume of 71451 shares. The stock lost 0.51% to Rs.1,915.00. Volumes stood at 4.47 lakh shares in the last session.
Rashtriya Chemicals & Fertilizers Ltd clocked volume of 6.8 lakh shares by 10:45 IST on BSE, a 10.77 times surge over two-week average daily volume of 63150 shares. The stock gained 5.42% to Rs.125.50. Volumes stood at 62227 shares in the last session.
IIFL Finance Ltd witnessed volume of 8.86 lakh shares by 10:45 IST on BSE, a 7.04 times surge over two-week average daily volume of 1.26 lakh shares. The stock dropped 3.07% to Rs.675.20. Volumes stood at 2.3 lakh shares in the last session.
Paradeep Phosphates Ltd recorded volume of 16.25 lakh shares by 10:45 IST on BSE, a 6.25 times surge over two-week average daily volume of 2.60 lakh shares. The stock gained 5.62% to Rs.157.85. Volumes stood at 1.75 lakh shares in the last session.
Syngene International Ltd, Voltas Ltd, Cera Sanitaryware Ltd, Sun TV Network Ltd are among the other stocks to see a surge in volumes on BSE today, 06 July 2026.
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 1.82 lakh shares by 10:46 IST on BSE, a 17.18 times surge over two-week average daily volume of 10602 shares. The stock lost 0.79% to Rs.2,373.85. Volumes stood at 4148 shares in the last session.
Syngene International Ltd clocked volume of 8.23 lakh shares by 10:46 IST on BSE, a 13.15 times surge over two-week average daily volume of 62545 shares. The stock lost 1.76% to Rs.432.50. Volumes stood at 24122 shares in the last session.
Voltas Ltd saw volume of 5.28 lakh shares by 10:46 IST on BSE, a 6.59 fold spurt over two-week average daily volume of 80170 shares. The stock increased 0.72% to Rs.1,291.30. Volumes stood at 1.89 lakh shares in the last session.
Cera Sanitaryware Ltd saw volume of 3713 shares by 10:46 IST on BSE, a 5.2 fold spurt over two-week average daily volume of 714 shares. The stock increased 2.09% to Rs.6,568.50. Volumes stood at 811 shares in the last session.
Sun TV Network Ltd notched up volume of 28289 shares by 10:46 IST on BSE, a 4 fold spurt over two-week average daily volume of 7066 shares. The stock slipped 0.89% to Rs.511.30. Volumes stood at 2606 shares in the last session.
Profit before tax was at Rs 369.12 crore in the March 2026 quarter, up 4% from Rs 354.9 crore recorded in corresponding quarter last year.
Total expenses marginally rose 0.78% to Rs 655.75 crore in Q4 FY26 over Q4 FY25. Cost of materials consumed was at Rs 101.47 crore (down 6.34% YoY) while employee benefits expense stood at Rs 164.75 crore (up 7.70% YoY) during the period under review.
EBITDA stood at Rs 347 crore in the quarter, up 5% year-on-year. EBITDA margin improved by 90 basis points to 35.1%.
The General Medicines portfolio delivered a competitive performance during the quarter, with the top four promoted brands outperforming the market, according to IQVIA data. Key brands including Augmentin, Calpol and T-Bact continued to maintain leadership positions in their respective categories, although the tail-end distributed portfolio faced significant headwinds.
The Vaccines business registered growth driven by strong demand and sustained leadership in the self-pay private paediatric vaccines segment. Shingrix (Recombinant Herpes Zoster Vaccine, Adjuvanted) achieved critical scale during the year amid rising awareness around preventive healthcare and adult immunisation.
The Oncology business, led by specialised therapies Jemperli (dostarlimab) and Zejula (niraparib), continued to witness strong traction. During the year, Jemperli received first-line approval from Indian regulators for primary advanced and recurrent endometrial cancer, significantly expanding the eligible patient pool and supporting long-term growth prospects in the oncology segment.
The company has received market authorisation in India for Blenrep (belantamab mafodotin), an anti-BCMA antibody-drug conjugate (ADC) therapy indicated for the treatment of relapsed or refractory multiple myeloma in adults.
Multiple myeloma is the third most common blood cancer globally, with around 180,000 new cases diagnosed annually. The company said launch plans for the therapy will be announced at an appropriate time.
Bhushan Akshikar, Managing Director, GSK India, said: “The strong delivery of our Oncology portfolio signals a key inflection point in GSK India’s journey to evolve into an innovation-led company, focused on areas of high unmet medical need. Our progress is underpinned by scientific rigour, disciplined execution and an unwavering commitment to our patients in India. Building on this momentum, we will continue to invest in innovative, high-growth therapy areas to make a positive impact at scale. Our ambition is driven by a sharp focus on topline growth and sustainable profitability.”
The board has recommended a final dividend of Rs 57 per equity share of face value Rs 10 each for the financial year ended March 31, 2026. The company has fixed May 29, 2026, as the record date for determining eligible shareholders for the final dividend. If approved at the AGM, the dividend will be paid on or after July 1, 2026, subject to deduction of tax at source.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GSK plc, a science-led global healthcare company with a purpose to unite science, technology and talent to get ahead of disease together.